48,474
edits
(→Phyllodes tumour: re-work) |
|||
Line 578: | Line 578: | ||
==Phyllodes tumour== | ==Phyllodes tumour== | ||
*Previously ''cystosarcoma phyllodes''. | |||
===General=== | ===General=== | ||
Line 588: | Line 588: | ||
===Gross=== | ===Gross=== | ||
*Clefts/leaf-like structures. | *Clefts/leaf-like structures. | ||
*Friable - | *Friable - especially vis-à-vis a [[fibroadenoma]]. | ||
Image: | Image: | ||
Line 617: | Line 617: | ||
*[http://en.wikipedia.org/wiki/File:Phyllodes_tumour_-_low_mag.jpg Phyllodes tumour - low mag. (WC)]. | *[http://en.wikipedia.org/wiki/File:Phyllodes_tumour_-_low_mag.jpg Phyllodes tumour - low mag. (WC)]. | ||
==== | ====Grading==== | ||
Phyllodes tumours are graded: | |||
* | *Benign. | ||
* | *Borderline. | ||
* | *Malignant. | ||
Grading phyllodes tumours - based on WMSP:<ref name=Ref_WMSP263>{{Ref WMSP|263}}</ref> | |||
{| class="wikitable" | {| class="wikitable" | ||
| | | Feature | ||
| Benign phyllodes | |||
| Borderline phyllodes | |||
| Malignant phyllodes | |||
|- | |||
| Circumscription | |||
| Well | |||
| Well | |||
| Poor | |||
|- | |||
| Stromal overgrowth † | |||
| none | |||
| none | |||
| may be present | |||
|- | |- | ||
| | | Nuclear atypia | ||
| mild | |||
| mild-to-moderate | |||
| moderate-to-marked | |||
|- | |- | ||
|Mitoses | | Mitoses per 10 [[HPF]]s ‡ | ||
| < 5 | |||
| 5-10 | |||
| >10 | |||
|- | |- | ||
| | | Heterologous elements | ||
| +/- benign | |||
| +/- benign | |||
| +/- malignant | |||
|- | |||
| DDx | |||
| [[fibroadenoma]] | |||
| benign phyllodes, malignant phyllodes | |||
| [[metaplastic breast carcinoma]], sarcoma | |||
|- | |- | ||
|} | |} | ||
Notes: | |||
* † Stromal overgrowth = epithelial elements absent in one low power field (LPF), defined as x40;<ref name=pmid17932112>{{cite journal |author=Taira N, Takabatake D, Aogi K, ''et al'' |title=Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin |journal=Jpn. J. Clin. Oncol. |volume=37 |issue=10 |pages=730-6 |year=2007 |month=October |pmid=17932112 |doi=10.1093/jjco/hym099 |url=http://jjco.oxfordjournals.org/cgi/reprint/37/10/730}}</ref> ''LPF'' is not adequately defined - see [[LPFitis]]. | |||
* ‡ ''HPF'' is not adequately defined - see [[HPFitis]]. | |||
==Pseudoangiomatous stromal hyperplasia== | ==Pseudoangiomatous stromal hyperplasia== |
edits